| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000024452 |
| P698 | PubMed publication ID | 11112863 |
| P2093 | author name string | R Louis | |
| J M Foidart | |||
| P Bartsch | |||
| C Munaut | |||
| F Frankenne | |||
| A Noël | |||
| D Cataldo | |||
| P433 | issue | 3 | |
| P921 | main subject | asthma | Q35869 |
| chronic obstructive pulmonary disease | Q199804 | ||
| sputum | Q259346 | ||
| P304 | page(s) | 259-267 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | International Archives of Allergy and Immunology | Q2189251 |
| P1476 | title | MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease | |
| P478 | volume | 123 |
| Q39029928 | Aryl hydrocarbon receptor (AhR) agonists increase airway epithelial matrix metalloproteinase activity |
| Q38776073 | Brain-derived neurotrophic factor and airway fibrosis in asthma. |
| Q36678349 | Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease |
| Q49987293 | Cigarette Smoke Induces Activation of Polymorphonuclear Leukocytes. |
| Q34598824 | Cigarette smoke-induced lung emphysema in mice is associated with prolyl endopeptidase, an enzyme involved in collagen breakdown. |
| Q26796418 | Complement mediators: key regulators of airway tissue remodeling in asthma |
| Q33622543 | Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency |
| Q37707616 | Detection and monitoring of localized matrix metalloproteinase upregulation in a murine model of asthma |
| Q35360761 | Differential expression of MMP-2 and -9 and their inhibitors in fetal lung cells exposed to mechanical stretch: regulation by IL-10. |
| Q84342847 | Diospyros blancoi attenuates asthmatic effects in a mouse model of airway inflammation |
| Q35210027 | Doxycycline inhibits matrix metalloproteinase-2 secretion from TSC2-null mouse embryonic fibroblasts and lymphangioleiomyomatosis cells. |
| Q50261297 | Establishment and Evaluation of a Rat Model of Sidestream Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease |
| Q38806133 | Experimental animal models for COPD: a methodological review. |
| Q35113726 | Expression of ADAMs and their inhibitors in sputum from patients with asthma |
| Q39467997 | Extracellular 14-3-3 from human lung epithelial cells enhances MMP-1 expression |
| Q36422095 | Fibrotic response as a distinguishing feature of resistance and susceptibility to pulmonary infection with Mycobacterium tuberculosis in mice |
| Q79789938 | Functional, inflammatory and morphological characterisation of a cat model of allergic airway inflammation |
| Q33923363 | HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue-Destructive Phenotype |
| Q33612246 | Highly Protective Association of MMP-2-1306C/T Promoter Polymorphism With Asthma in a North Indian Population: A Pilot Study |
| Q75410348 | Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas |
| Q35201780 | Induced sputum in the investigation of airway inflammation of COPD. |
| Q28388551 | Inflammasome activation in airway epithelial cells after multi-walled carbon nanotube exposure mediates a profibrotic response in lung fibroblasts |
| Q38108292 | Inflammatory signalings involved in airway and pulmonary diseases |
| Q47782299 | Interleukin-13-dependent expression of matrix metalloproteinase-12 is required for the development of airway eosinophilia in mice |
| Q35816380 | Involvement of Toll-like receptor 2 and epidermal growth factor receptor signaling in epithelial expression of airway remodeling factors |
| Q27022636 | Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases |
| Q42092256 | Long-term use of doxycycline can improve chronic asthma and possibly remodeling: the result of a pilot observation |
| Q26741827 | Matrix Metalloproteinases in Non-Neoplastic Disorders |
| Q91614684 | Matrix metalloproteinase activity in the lung is increased in Hermansky-Pudlak syndrome |
| Q35747617 | Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation |
| Q37224482 | Matrix metalloproteinases -8, -9 and -12 in smokers and patients with stage 0 COPD. |
| Q31891500 | Matrix metalloproteinases and TIMP-1 production by peripheral blood granulocytes from COPD patients and asthmatics |
| Q51033052 | Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mRNA transcripts in the bronchial secretions of asthmatics. |
| Q23915773 | Matrix metalloproteinases, IL-8 and glutathione in the prognosis of workers exposed to chlorine |
| Q43125830 | Metalloproteinases and Their Tissue Inhibitors in Comparison between Different Chronic Pneumopathies in the Horse |
| Q91970216 | Metalloproteinases and their Inhibitors under the Course of Immunostimulation by CPG-ODN and Specific Antigen Inhalation in Equine Asthma |
| Q36219151 | Metalloproteinases and their inhibitors are influenced by inhalative glucocorticoid therapy in combination with environmental dust reduction in equine recurrent airway obstruction |
| Q53018534 | MicroPET Evaluation of a Hydroxamate-Based MMP Inhibitor, [(18)F]FB-ML5, in a Mouse Model of Cigarette Smoke-Induced Acute Airway Inflammation. |
| Q36440308 | Muscarinic receptors and their antagonists in COPD: anti-inflammatory and antiremodeling effects |
| Q47159534 | Neutrophil-Derived Interleukin 16 in Premetastatic Lungs Promotes Breast Tumor Cell Seeding |
| Q36994670 | Neutrophils in asthma |
| Q33673851 | ORMDL3 is associated with airway remodeling in asthma via the ERK/MMP-9 pathway |
| Q37407320 | Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines |
| Q36013653 | Plasminogen is an important regulator in the pathogenesis of a murine model of asthma |
| Q58800123 | Protective Effect of Jianpiyifei II Granule against Chronic Obstructive Pulmonary Disease via NF-B Signaling Pathway |
| Q53658856 | Protective effect of emodin against airway inflammation in the ovalbumin-induced mouse model. |
| Q36130794 | Protective role of matrix metalloproteinase-9 in ozone-induced airway inflammation |
| Q36305351 | Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease |
| Q55229524 | Proteolytic biomarkers are related to prognosis in COPD- report from a population-based cohort. |
| Q37426720 | Recent advances in pre-clinical mouse models of COPD. |
| Q35218974 | Regulation of nasal airway homeostasis and inflammation in mice by SHP-1 and Th2/Th1 signaling pathways |
| Q37070325 | Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease |
| Q30925905 | Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study |
| Q37115916 | Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro |
| Q41898523 | Sustained elevation of systemic oxidative stress and inflammation in exacerbation and remission of asthma |
| Q37578310 | Targeting lung inflammation: novel therapies for the treatment of COPD. |
| Q35843820 | The Therapeutic Effects of Optimal Dose of Mesenchymal Stem Cells in a Murine Model of an Elastase Induced-Emphysema |
| Q34128938 | Tiotropium bromide inhibits TGF-ß-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro |
Search more.